Literature DB >> 8556346

Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock.

S F Maier1, L R Watkins.   

Abstract

Brain interleukin-1 (IL-1) plays a key role in mediating the neural, endocrine, and behavioral consequences of injury and infection. Recent evidence indicates that brain IL-1 may also be important in producing endocrine and neurochemical responses to stressors. The present experiment sought to determine whether intracerebroventricular (i.c.v.) administration of an interleukin-1 receptor antagonist (IL-1ra) would block behavioral effects of a stressor. I.c.v. application of hrIL-1ra before inescapable shock blocked the subsequent interference with escape learning and enhancement of fear conditioning normally produced by this treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8556346     DOI: 10.1016/0006-8993(95)00930-o

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  43 in total

Review 1.  Hypothalamic mechanisms in cachexia.

Authors:  Aaron J Grossberg; Jarrad M Scarlett; Daniel L Marks
Journal:  Physiol Behav       Date:  2010-03-25

Review 2.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

3.  Anti-inflammatory agents attenuate the passive responses of guinea pig pups: evidence for stress-induced sickness behavior during maternal separation.

Authors:  Michael B Hennessy; Patricia A Schiml-Webb; Emily E Miller; Deborah S Maken; Katie L Bullinger; Terrence Deak
Journal:  Psychoneuroendocrinology       Date:  2007-04-25       Impact factor: 4.905

Review 4.  Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.

Authors:  Heath D Schmidt; Richard C Shelton; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

Review 5.  Neurobiology of resilience in depression: immune and vascular insights from human and animal studies.

Authors:  Katarzyna A Dudek; Laurence Dion-Albert; Fernanda Neutzling Kaufmann; Ellen Tuck; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2019-09-13       Impact factor: 3.386

6.  Inflaming depression.

Authors:  Hymie Anisman
Journal:  J Psychiatry Neurosci       Date:  2011-09       Impact factor: 6.186

Review 7.  Neuroimmune mechanisms of stress: sex differences, developmental plasticity, and implications for pharmacotherapy of stress-related disease.

Authors:  Terrence Deak; Matt Quinn; John A Cidlowski; Nicole C Victoria; Anne Z Murphy; John F Sheridan
Journal:  Stress       Date:  2015-07-15       Impact factor: 3.493

8.  Immunization with Mycobacterium vaccae induces an anti-inflammatory milieu in the CNS: Attenuation of stress-induced microglial priming, alarmins and anxiety-like behavior.

Authors:  Matthew G Frank; Laura K Fonken; Samuel D Dolzani; Jessica L Annis; Philip H Siebler; Dominic Schmidt; Linda R Watkins; Steven F Maier; Christopher A Lowry
Journal:  Brain Behav Immun       Date:  2018-05-26       Impact factor: 7.217

9.  Facilitated acquisition of the classically conditioned eyeblink response in male rats after systemic IL-1beta.

Authors:  Richard J Servatius; Kevin D Beck
Journal:  Integr Physiol Behav Sci       Date:  2003 Jul-Sep

10.  Sympathetic nervous system contributes to enhanced corticosterone levels following chronic stress.

Authors:  Steven A Lowrance; Amy Ionadi; Erin McKay; Xavier Douglas; John D Johnson
Journal:  Psychoneuroendocrinology       Date:  2016-02-26       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.